Results 71 to 80 of about 4,299 (147)

Abstracts From PVRI 2026 Dublin

Pulmonary Circulation, Volume 16, Issue 2, June 2026.
wiley   +1 more source

Endothelin-1 in the failing Fontan: pathobiology, precision therapeutics, and future trial design

Frontiers in Pediatrics
The Fontan circulation, devised as definitive palliation for single-ventricle congenital heart disease, imposes systemic venous hypertension, loss of pulmonary arterial pulsatility, and restricted preload reserve.
Iman Maiza
doaj   +1 more source

Revisiting Hepatic Fibrosis Risk in Congenital Heart Disease: Insights from Non-Invasive Markers and Echocardiography

Children
Background/Objectives: This study aimed to investigate the prevalence of liver damage and its associated non-invasive markers and echocardiographic risk factors in patients who underwent surgery for congenital heart disease.
Fusako Yamazaki, Hiroteru Kamimura, Saori Endo, Suguru Miida, Hiroki Maruyama, Tomoaki Yoshida, Masaru Kumagai, Naruhiro Kimura, Hiroyuki Abe, Akira Sakamaki, Takeshi Yokoo, Masanori Tsukada, Fujito Numano, Akihiko Saitoh, Maya Watanabe, Shuichi Shiraishi, Masanori Tsuchida, Shinya Fujiki, Takeshi Kashimura, Takayuki Inomata, Hirofumi Nonaka, Kenya Kamimura, Atsunori Tsuchiya, Shuji Terai   +23 more
doaj   +1 more source

Association of Fontan Pathophysiology With Plasma Bile Acids

JACC: Advances
Background: Patients with Fontan circulation are frail and experience multisystem dysfunction including impaired exercise capacity, low resting and exercise-augmented cardiac output, and progressive liver fibrosis.
Ashish H. Shah, MD, MD-Research, Arun Surendran, MSc, Pedram Hassan-Tash, BSc, MD, C. Nolan Turnbull, BSc, Nicole Johnston, MSc, David Goodlett, BSc, PhD, Jun Han, PhD, Robin A. Ducas, MD, James W. Tam, MD, Eberhard Renner, MD, Todd A. Duhamel, PhD, Michel Aliani, MSc, PhD, Amir Ravandi, MD, PhD, Richard A. Krasuski, MD   +13 more
doaj   +1 more source

Fontan-Associated Liver Disease

Journal of the American College of Cardiology, 2017
Curt J. Daniels, Elisa A. Bradley, Mike J. Landzberg, Jamil Aboulhosn, Robert H. Beekman, Wendy Book, Michelle Gurvitz, Anitha John, Binu John, Ariane Marelli, Bradley S. Marino, L. LuAnn Minich, John J. Poterucha, Elizabeth B. Rand, Gruschen R. Veldtman   +14 more
openaire   +1 more source

Imaging findings in Fontan-associated liver disease: Results of a single center study. [PDF]

Int J Cardiol Congenit Heart Dis
Lewis S, Mazurek R, Nemzow G, Hopkins K, Fiel I, Chan A, Facciuto M, Taouli B, Schiano TD, Zaidi A, Grinspan L.   +10 more
europepmc   +1 more source

Fontan Associated Liver Disease: Canary in the Coal Mine or Silent Killer? [PDF]

J Am Heart Assoc, 2023
Haeffele C, McElhinney DB.
europepmc   +1 more source

Limited association between liver stiffness and clinical outcomes in Fontan-associated liver disease: a retrospective analysis. [PDF]

Int J Cardiol Congenit Heart Dis
Cai L, Choudhary P, Tanous D, George J.
europepmc   +1 more source

Long-Term Care in Fontan Circulation: Surveillance and Management of Fontan-Associated Liver Disease and Protein-Losing Enteropathy. [PDF]

Curr Cardiol Rep
Jarasvaraparn C, Schooler GR, González IA, Ginde S, Mavis A.   +4 more
europepmc   +1 more source

Hepatocellular carcinoma in Fontan-associated liver disease: Incidence, risk stratification, and surveillance implications. [PDF]

Hepatol Commun
Onishi H, Toh N, Baba K, Kotani Y, Kasahara S, Otsuka M.   +5 more
europepmc   +1 more source